WKN DE: A2AA7B / ISIN: US05464T1043

prices + charts + realtime		news + analysis	fundamental	company	corresponding shares	action
price + Chart	chart (large)	news + ad-hoc	balance sheet/p&l	fixed dates	certificates	portfolio#add_instrument_to#depot
times + sale	chart comparison	analysis	detailnavigation#shares#estimates	profile	warrants	portfolio#add_instrument_to#watchlist
stock exchange	realtime push	stock price appreciation potential	dividend/annual shareholders' meeting	knockouts
historic	analysis

prices + charts + realtime
price + Chart
times + sale
stock exchange
historic

news + analysis
news + ad-hoc
analysis
stock price appreciation potential

fundamental
balance sheet/p&l
detailnavigation#shares#estimates
dividend/annual shareholders' meeting
analysis

company
fixed dates
profile

corresponding shares
certificates
warrants
knockouts

Axsome Therapeutics times and sales (STU)

time	price	transaction volume	transaction volume graphical
Times and Sales derivativetimesandsales: notass

retreat of prices	increase in prices	no change in prices
shares#timesandsales#barchartdescription

news about Axsome Therapeutics Inc

04.05.2025 07:01:06		Ausblick: Axsome Therapeutics vermeldet Zahlen zum jüngsten Quartal
17.02.2025 07:01:06		Ausblick: Axsome Therapeutics stellt das Zahlenwerk zum vergangenen Quartal vor
03.02.2025 06:21:33		Erste Schätzungen: Axsome Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt
11.11.2024 07:01:06		Ausblick: Axsome Therapeutics mit Zahlen zum abgelaufenen Quartal
28.10.2024 06:21:34		Erste Schätzungen: Axsome Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt
04.08.2024 07:01:06		Ausblick: Axsome Therapeutics vermeldet Zahlen zum jüngsten Quartal
21.07.2024 06:21:34		Erste Schätzungen: Axsome Therapeutics öffnet die Bücher zum abgelaufenen Quartal
05.05.2024 07:01:06		Ausblick: Axsome Therapeutics gewährt Anlegern Blick in die Bücher

analysis to Axsome Therapeutics Inc

Weitere Meldungen

02:13		Trump says decision on Fed chair will be out soon
01:46		The S&P 500 isn’t changing for now. Did this company get snubbed?
01:34		Why Dollar General Stock Zoomed Nearly 17% Higher This Week
01:30		Titan: The OceanGate Disaster — a tale of hubris and serious mismanagement
01:26		Jillian Sackler, Philanthropist Who Defended Husband’s Legacy, Dies at 84
01:22		Why Analog Devices Stock Topped the Market Today
01:10		Why Applied Digital Stock Soared Again Today
01:00		New OCBC offer for Great Eastern more attractive but fate lies in hands of significant minority shareholders: analysts
01:00		UFC 316: Merab Dvalishvili vs. Sean O'Malley: Watch Livestream, Start Time, Full Card
00:58		Trump Has Options to Punish Musk Even if His Federal Contracts Continue
00:45		$1000 Invested In Republic Services 5 Years Ago Would Be Worth This Much Today
00:42		Lies of P: Overture DLC Drops Out of Nowhere During Summer Game Fest
00:34		My Switch 2 Review in Progress: It's Good, but Don't Give In to the FOMO Yet
00:30		$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
00:30		Supreme Court grants DOGE access to Social Security data, days after Musk stepped down
00:15		If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
00:00		P/E Ratio Insights for Greystone Housing Impact
00:00		Google's AI Mode Now Creates Interactive Stock Charts For You
06.06.25		Despite War of Words, Trump May Funnel Billions to Musk's Starlink With BEAD Changes
06.06.25		Musk’s feud with Trump muddies xAI debt raising for Morgan Stanley
06.06.25		Musk’s feud with Trump muddies xAI debt raising for Morgan Stanley
06.06.25		1 Wall Street Analyst Thinks Palantir Will Be a Trillion-Dollar Company. Can It Get There?
06.06.25		Summer Game Fest: A Warcraft-Style Game of Thrones RTS Is Coming in 2026
06.06.25		Palantir Rises 2.6% After Key Trading Signal
06.06.25		$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
06.06.25		Where Will Apple Stock Be in 5 Years?
06.06.25		AMC Says It Will Show More Ads Before Movies
06.06.25		$100 Invested In CACI International 15 Years Ago Would Be Worth This Much Today
06.06.25		Prediction: This Artificial Intelligence (AI) Stock Will Be Worth $3 Trillion in 5 Years
06.06.25		Drones are a security concern for Americans — but this could be an even bigger threat
06.06.25		Buyer With Ties to Chinese Communist Party Got V.I.P. Treatment at Trump Crypto Dinner
06.06.25		A Look Into Motorola Solutions Inc's Price Over Earnings
06.06.25		$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
06.06.25		Braze Grows Revenue and Expands AI Suite
06.06.25		Tokyo Disney Resort operator considers cutting ticket prices for theme parks
06.06.25		Why Samsara Stock Sank Today
06.06.25		$100 Invested In Somnigroup International 15 Years Ago Would Be Worth This Much Today
06.06.25		US Labor Market Shows Resilience, Tesla Slumps After Trump-Musk Feud: This Week In Markets
06.06.25		Netflix Review: Our Top Pick in a Sea of Streaming Choices
06.06.25		If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
06.06.25		Broadcom Gets Mixed Reactions As Modest Earnings Beat Sparks Profit-Taking
06.06.25		EU asked to intervene as US sanctions deal fresh blow to ICC
06.06.25		This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago
06.06.25		Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?
06.06.25		Looking At Rivian Automotive's Recent Unusual Options Activity
06.06.25		If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
06.06.25		A Look Into Automatic Data Processing Inc's Price Over Earnings
06.06.25		Is the Market Bullish or Bearish on PENN Entertainment?
06.06.25		How Is The Market Feeling About Prosperity Bancshares?
06.06.25		Is the Market Bullish or Bearish on JM Smucker?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Solar Integrated Roofing QuickCool AB PUF Ventures Grow Condos Medical Transcription Billing a

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

portfolio#entry#portfolio_name: portfolio#entry#watchlist_name:
portfolio#entry#portfolio:
portfolio#entry#name:
portfolio#entry#instrumenttype:
portfolio#entry#identifier:
portfolio#entry#exchange:
portfolio#entry#size:
portfolio#entry#current_quote:
portfolio#entry#current_quotetime:
portfolio#entry#buying_price:
portfolio#entry#buying_date:	07.06.2025 04:04:19
portfolio#entry#buying_worth:	EUR
	portfolio#addinstrumenttoportfolio#submit

Axsome Therapeutics share#snapshot#suffix

WKN DE: A2AA7B / ISIN: US05464T1043

Axsome Therapeutics times and sales (STU)

Times and Sales

news about Axsome Therapeutics Inc

analysis to Axsome Therapeutics Inc

Weitere Meldungen